SUDEEP PHARMA
Back to Income Statement
|
SUDEEP PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹502 Cr | ₹459 Cr | ₹429 Cr | ₹343 Cr | ₹215 Cr |
What is the latest Revenue of SUDEEP PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹502 Cr |
| Mar2024 | ₹459 Cr |
| Mar2023 | ₹429 Cr |
| Mar2022 | ₹343 Cr |
| Mar2021 | ₹215 Cr |
How is Revenue of SUDEEP PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹502 Cr | 9.30 | |
| Mar2024 | ₹459 Cr | 7.12 | |
| Mar2023 | ₹429 Cr | 24.99 | |
| Mar2022 | ₹343 Cr | 59.46 | |
| Mar2021 | ₹215 Cr | - | |
Compare Revenue of peers of SUDEEP PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDEEP PHARMA | ₹9,135.3 Cr | -4.2% | 16.3% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,792.0 Cr | 1.4% | 1.2% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,152.0 Cr | -0.5% | -0.6% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,915.0 Cr | 2.1% | 1.5% | 42.2% | Stock Analytics | |
| CIPLA | ₹116,354.0 Cr | 6.4% | 1.6% | -3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,681.0 Cr | 6.2% | 1.6% | 0.2% | Stock Analytics | |
SUDEEP PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDEEP PHARMA | -4.2% |
16.3% |
|
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses